Pharvaris N.V. (PHVS)
NASDAQ: PHVS · Real-Time Price · USD
27.05
-0.74 (-2.66%)
Jan 30, 2026, 4:00 PM EST - Market closed
Pharvaris Market Cap
Pharvaris has a market cap or net worth of $1.76 billion as of January 30, 2026. Its market cap has increased by 94.59% in one year.
Market Cap
1.76B
Enterprise Value
1.37B
1-Year Change
94.59%
Ranking
Category
Stock Price
$27.05
Market Cap Chart
Since the IPO on February 5, 2021, Pharvaris's market cap has increased from $636.80M to $1.76B, an increase of 175.94%. That is a compound annual growth rate of 22.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 1.76B | -2.52% |
| Dec 31, 2025 | 1.80B | 73.39% |
| Dec 31, 2024 | 1.04B | -28.87% |
| Dec 29, 2023 | 1.46B | 284.53% |
| Dec 30, 2022 | 380.11M | -20.27% |
| Dec 31, 2021 | 476.72M | -25.14% |
| Feb 5, 2021 | 636.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zai Lab | 1.85B |
| Vericel | 1.82B |
| Nuvation Bio | 1.80B |
| MannKind | 1.77B |
| Syndax Pharmaceuticals | 1.77B |
| Corvus Pharmaceuticals | 1.73B |
| Stoke Therapeutics | 1.73B |
| Nurix Therapeutics | 1.70B |